Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer

N Joseph, S J Dovedi, C Thompson, J Lyons, J Kennedy, T Elliott, C M West, A Choudhury

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Pre-treatment lymphocytopaenia is an adverse prognostic biomarker in muscle-invasive and advanced bladder cancer'. Together they form a unique fingerprint.

Medicine and Dentistry